Global MicroRNA Expression Profiling of High-Risk ER+ Breast Cancers from Patients Receiving Adjuvant Tamoxifen Mono-Therapy: A DBCG Study

por Lyng, Maria B., Lænkholm, Anne-Vibeke, Søkilde, Rolf, Gravgaard, Karina H., Litman, Thomas, Ditzel, Henrik J.
Publicado 2012

Novel circulating microRNA signature as a potential non‐invasive multi‐marker test in ER‐positive early‐stage breast cancer: A case control study

por Kodahl, Annette R., Lyng, Maria B., Binder, Harald, Cold, Søren, Gravgaard, Karina, Knoop, Ann S., Ditzel, Henrik J.
Publicado 2014

Gene Expression Signatures That Predict Outcome of Tamoxifen-Treated Estrogen Receptor-Positive, High-Risk, Primary Breast Cancer Patients: A DBCG Study

por Lyng, Maria B., Lænkholm, Anne-Vibeke, Tan, Qihua, Vach, Werner, Gravgaard, Karina H., Knoop, Ann, Ditzel, Henrik J.
Publicado 2013